SCHEMBL13638646

SCHEMBL13638646

CC1CC=C(S(=O)(=O)NC(=O)Nc2ccc(-n3cnc4cc(NCCN(C)C)ccc4c3=O)cc2)S1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ATM Q13315 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12177643 0.91 ATM (0.35) ATM
SCHEMBL13638703 0.87 ATM (0.34) ATM
SCHEMBL13638705 0.82 ATM (0.43) ATM
SCHEMBL12161316 0.81 P2RY12 (0.46) ATM
SCHEMBL13638585 0.80 TERT (0.35) ATM
SCHEMBL14113578 0.79 ESR1 (0.37) ATM
SCHEMBL12177083 0.78 MEN1 (0.31) ATM
SCHEMBL13638542 0.76 PPARG (0.39)
SCHEMBL13638647 0.74 P2RY12 (0.39) ATM
SCHEMBL13638373 0.73 ATM (0.37) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed